← Back
$AURA All transactions

Aura Biosciences, Inc.

A

$ Value

$0

Shares

44,528

Price

$0

Filed

Mar 3

Insider

Name

Elazzouzi Amy

Title

Senior Vice President, Finance

CIK

0002042910

Roles

Officer

Transaction Details

Transaction Date

2026-03-02

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

120,060

Footnotes

These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on January 15, 2027, subject to the Reporting Person's continued service as of each such vesting date. | The shares underlying this option vest as follows: 25% of the shares vest on February 1, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date.

Filing Info

Accession No.

0001193125-26-088150

Form Type

4

Issuer CIK

0001501796

Elazzouzi Amy's History

Date Ticker Type Value
2026-03-02 AURA A $0
2026-03-02 AURA A $0
2026-02-17 AURA $43K
2026-01-20 AURA $8K
2025-10-29 AURA $6K
2025-08-18 AURA M $13K
2025-08-18 AURA M $6K
2025-08-18 AURA M $3K
2025-08-18 AURA M $3K
2025-08-18 AURA M $13K

Other Insiders at AURA (90d)

Insider Bought Sold Last
Gibney Anthony S
See Remarks
2026-03-02
Kilroy Conor
See Remarks
$143K 2026-04-16
Plavsic Mark
Chief Technology Officer
$80K 2026-03-02
de los Pinos Elisabet
See Remarks
$241K 2026-03-02
Hopkins Janet Jill
Chief Medical Officer
$103K 2026-03-02
Elazzouzi Amy
Senior Vice President, Finance
$43K 2026-03-02